Works matching IS 25094254 AND DT 2023 AND VI 7 AND IP 5

Results: 13

Cost Effectiveness of Different Platelet Preparation, Storage, Selection and Dosing Methods in Platelet Transfusion: A Systematic Review.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 679, doi. 10.1007/s41669-023-00427-w

By:

Laermans, Jorien;
Van Remoortel, Hans;
Scheers, Hans;
Avau, Bert;
Georgsen, Jørgen;
Nahirniak, Susan;
Shehata, Nadine;
Stanworth, Simon J.;
De Buck, Emmy;
Compernolle, Veerle;
Vandekerckhove, Philippe

Publication type:

Article

Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England.

Published in:

2023

By:

Bromilow, Tom;
Holmes, Hayden;
Coote, Laura;
Woods, Sam;
Pink, Joshua

Publication type:

Correction Notice

Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 751, doi. 10.1007/s41669-023-00430-1

By:

Vestergaard, Anne Høy Seemann;
Ehlers, Lars Holger;
Neergaard, Mette Asbjoern;
Christiansen, Christian Fynbo;
Valentin, Jan Brink;
Johnsen, Søren Paaske

Publication type:

Article

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 851, doi. 10.1007/s41669-023-00429-8

By:

Khair, Andrew;
Brown, Tray;
Markert, Marie;
Barsøe, Carsten Rødseth;
Daftary, Gaurang S.;
Heiser, Patrick W.

Publication type:

Article

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 777, doi. 10.1007/s41669-023-00426-x

By:

Shupo, Francis;
Abrams, Keith R.;
Ademi, Zanfina;
Wayi-Wayi, Grace;
Zibelnik, Natasa;
Kirchmann, Matt;
Rutherford, Carolyn;
Makarounas-Kirchmann, Kelly

Publication type:

Article

Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 739, doi. 10.1007/s41669-023-00420-3

By:

Bromilow, Tom;
Holmes, Hayden;
Coote, Laura;
Woods, Sam;
Pink, Joshua

Publication type:

Article

Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn's Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 811, doi. 10.1007/s41669-023-00424-z

By:

Karki, Chitra;
Latremouille-Viau, Dominick;
Gilaberte, Inmaculada;
Hantsbarger, Gary;
Romdhani, Hela;
Lightner, Amy L.

Publication type:

Article

Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 723, doi. 10.1007/s41669-023-00423-0

By:

Jovanoski, Nick;
Abogunrin, Seye;
Di Maio, Danilo;
Belleli, Rossela;
Hudson, Pollyanna;
Bhadti, Sneha;
Jones, Libby G.

Publication type:

Article

Perceptions and Attitudes Regarding Medical Device Development in Canada Among Canadian Innovators: A Qualitative Study.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 793, doi. 10.1007/s41669-023-00422-1

By:

Browne, Ikennah L.;
Sutton, Andrew J.;
Zhang, Wei

Publication type:

Article

Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 765, doi. 10.1007/s41669-023-00425-y

By:

Philipson, Anna;
Hagberg, Lars;
Hermansson, Liselotte;
Karlsson, Jan;
Ohlsson-Nevo, Emma;
Ryen, Linda

Publication type:

Article

Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn's Disease and Ulcerative Colitis.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 823, doi. 10.1007/s41669-023-00419-w

By:

Loftus Jr, Edward V.;
Ananthakrishnan, Ashwin N.;
Lee, Wan-Ju;
Gonzalez, Yuri Sanchez;
Fitzgerald, Kristina A;
Wallace, Kori;
Zhou, Wen;
Litcher-Kelly, Leighann;
Ollis, Sarah B.;
Su, Sylvia;
Danese, Silvio

Publication type:

Article

Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 709, doi. 10.1007/s41669-023-00415-0

By:

Jhaveri, Kenar D.;
Bensink, Mark E.;
Bunke, Martin;
Briggs, Jonathon A.;
Cork, David M. W.;
Jeyabalan, Anushya

Publication type:

Article

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico.

Published in:

PharmacoEconomics - Open, 2023, v. 7, n. 5, p. 841, doi. 10.1007/s41669-023-00421-2

By:

Garnica-Cuellar, Juan Carlos;
Morales-Villegas, Enrique;
López-Forero, Carmen Alicia;
Monroy-Cruz, Bárbara;
Pariti, Bhrugu;
Deshwal, Swati;
Sekharan, Manisha;
Osorio-Hernández, Mariana;
García-Appendini, Ida Caterina

Publication type:

Article